Abstract
Summary
The intravenous administration of 0.5 mg of dihydroergocornine to 24 patients with left ventricular hypertrophy caused no electrocardiographic changes indicative of coronary vasoconstriction. Although 6 of the 24 patients suffered from anginal pain and many more certainly had coronary disease, no angina pectoris followed the injection.
This particular alkaloid of ergot seems to be a safe drug in patients with coronary artery disease.
Get full access to this article
View all access options for this article.